Mark Wiley is a Cardiology physician affiliated with University of Kansas Medical Center. OpenAlex indexes 78 publications with 537 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4000 Cambridge Street Ste G600
Kansas City, KS 661608501
Telephone
913-588-9600Registry record last updated 18 Dec 2018.
Industry payments
13 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Edwards Lifesciences CorporationProgram year202515 payments
- Medtronic, Inc.Program year202527 payments
- Abbott LaboratoriesProgram year20255 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
89%Statin19.9%Atorvastatin Calcium50%Rosuvastatin Calcium45%Pravastatin Sodium5%Part D<11 patientsBeta blocker16.5%Carvedilol41%Metoprolol Succinate37%Metoprolol Tartrate19%Nebivolol Hcl3%Part D≥55 patients+ 12 more classes in this area
Blood & clotting
7.3%Factor Xa inhibitor3.8%Eliquis75%Xarelto25%Part D<11 patientsP2Y12 inhibitor2%Clopidogrel100%Part D≥22 patients+ 1 more class in this area
Metabolism & gastrointestinal
2.4%Potassium supplement2.4%Potassium Chloride100%Part D≥23 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- CLINICAL FEATURES AND OUTCOMES OF ACCESS-RELATED RADIAL ARTERY PSEUDOANEURYSM: A SINGLE CENTER STUDY
Journal of the American College of Cardiology
2025 - Outcomes of peripheral artery disease and polyvascular disease in patients with end-stage kidney disease
Journal of Vascular Surgery
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Mario Castro, MD
University of Kansas Medical Center
Jeffrey Burns, MD
University of Kansas Medical Center
Gary Gronseth, MD
University of Kansas Medical Center
Mazen Dimachkie, MD
University of Kansas Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”